Logo for University of Iowa Health Care This logo represents the University of Iowa Health Care

Research article published by Dr. Jian Zhang and colleagues is designated as a ‘Top Reads’ paper by the Journal of Immunology

Invasive Candida infection is one of the leading causes of hospital-acquired bloodstream infections, which carry a mortality rate ranging from 45 to 75 percent. Toxicity and resistance to the limited number of anti-fungal agents currently available contributes to high morbidity and mortality associated with invasive fungal infections. Therefore, there is an urgent need to better understand the host-pathogen interaction during fungal infection and develop new immuno-therapeutic approaches to fight invasive candidiasis.

Dr. Bing Li receives a five-year U01 research grant from the National Cancer Institute investigating dysregulated lipid metabolism and cancer risk

Dr. Bing Li received a five-year NIH U01 award entitled “Determine the Molecular and Metabolic Mechanisms by which A-FABP Links Dysregulated Lipid Metabolism-induced Obesity/Breast Cancer Risk”. This award in combination with four other selected projects and a Coordinating Center will constitute the National Cancer Institute (NCI) Metabolic Dysregulation and Cancer Risk Program, which will focus on metabolic dysregulation as the key process linking obesity with cancer risk.

Pathology Fellow Alex Isaacson Interviewed for CAP Today on Importance of Pathology Externship in Generating Interest in Pathology for Medical Students

Current surgical pathology fellow and former pathology resident Alex Isaacson, MD, was interviewed for CAP Today on the importance of the University of Iowa pathology externship (‘post-sophomore fellowship’) in her own journey into pathology as a career and also as a recruitment tool for generating interest in pathology for medical students.

Dr. Hasem Habelhah receives a five-year R01 research grant from the National Institutes of Health investigating the role of the TRAF2-RIP1 pathway in breast cancer

Dr. Hasem Habelhah received a five-year NIH R01 entitled ‘The Roles of TRAF2 and RIP1 in Breast Cancer Cell Survival’ from the National Cancer Institute (NCI).

Article defining reference ranges for lab tests in the transgender population published in The Journal of Applied Laboratory Medicine

The article, entitled Reference Intervals for Clinical Chemistry Analytes for Transgender Men and Women on Stable Hormone Therapy, defines reference intervals (“normal ranges”) for frequently ordered laboratory tests including creatinine (kidney function), liver enzymes, and lipids in healthy transgender people.